2026 Qingbo Xu: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	122	590	527	33	31	489	46559
Medicine	122	3505	3274	347	332	499	46752

Research.com Recognitions

2026 - Research.com Biology and Biochemistry in United Kingdom Leader Award
2025 - Research.com Biology and Biochemistry in United Kingdom Leader Award
2023 - Research.com Biology and Biochemistry in United Kingdom Leader Award

Overview

Qingbo Xu is affiliated with Queen Mary University of London in the United Kingdom. Their research spans several fields, predominantly in Medicine and Biochemistry, Genetics and Molecular Biology.

The main fields of study covered by Xu include:

Medicine
Biochemistry, Genetics and Molecular Biology

Their subfields of specialization are:

Molecular Biology
Cardiology and Cardiovascular Medicine
Surgery
Immunology
Cancer Research

The major topics addressed in Xu's work include:

Angiogenesis and VEGF in Cancer
Single-cell and spatial transcriptomics
COVID-19 Clinical Research Studies
Atherosclerosis and Cardiovascular Diseases
MicroRNA in disease regulation
Extracellular vesicles in disease
Congenital heart defects research

Qingbo Xu frequently publishes in several notable venues. Among these are:

Circulation Research
Cell Metabolism
Hypertension
Cellular and Molecular Life Sciences
Circulation

Notable recent publications authored or co-authored by Xu include:

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19, 2020, Circulation Research
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19, 2020, Cell Metabolism
Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women, 2020, Journal of the American College of Cardiology
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes, 2020, Cell Metabolism
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19, 2020, Hypertension

Xu collaborates frequently with a group of co-authors, including:

Jingjing Cai
Yanhua Hu
Yibin Wang
Peng Zhang
Zhi-Gang She

Best Publications

Activation of Mitogen-activated Protein Kinase by H2O2: ROLE IN CELL SURVIVAL FOLLOWING OXIDANT INJURY (∗)

Kathryn Z. Guyton;Yusen Liu;Myriam Gorospe;Qingbo Xu

1513
Citations
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Peng Zhang;Lihua Zhu;Jingjing Cai;Fang Lei

1344
Citations
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice

Yanhua Hu;Zhongyi Zhang;Evelyn Torsney;Ali R. Afzal

794
Citations
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.

Q. Xu;G. Wick;J. Willeit;M. Marosi

737
Citations
Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study

Stefan Kiechl;Georg Egger;Manuel Mayr;Christian J. Wiedermann

716
Citations
Vascular repair by endothelial progenitor cells.

Anna Zampetaki;John Paul Kirton;Qingbo Xu

647
Citations
Autoimmune and Inflammatory Mechanisms in Atherosclerosis

Georg Wick;Michael Knoflach;Qingbo Xu

583
Citations
Is atherosclerosis an immunologically mediated disease

Georg Wick;Georg Schett;Albert Amberger;Roman Kleindienst

583
Citations
Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.

Georg Schett;Makiyeh Tohidast-Akrad;Josef S. Smolen;Beatrice Jahn Schmid

518
Citations
Role of Heat Shock Proteins in Atherosclerosis

Qingbo Xu

501
Citations
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.

Xiao Jing Zhang;Juan Juan Qin;Xu Cheng;Lijun Shen

472
Citations
Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65.

Qingbo Xu;H. Dietrich;H. J. Steiner;A. M. Gown

469
Citations
Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis.

Manuel Mayr;Bernhard Metzler;Stefan Kiechl;Johann Willeit

459
Citations
Serum Soluble Heat Shock Protein 60 Is Elevated in Subjects With Atherosclerosis in a General Population

Qingbo Xu;Georg Schett;Hannes Perschinka;Manuel Mayr

448
Citations
Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.

Manuel Mayr;Stefan Kiechl;Johann Willeit;Georg Wick

427
Citations
Mechanical stress-initiated signal transductions in vascular smooth muscle cells.

Chaohong Li;Qingbo Xu

378
Citations
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study.

Qingbo Xu;Stefan Kiechl;Manuel Mayr;Bernhard Metzler

361
Citations
Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.

R. Kleindienst;Qingbo Xu;J. Willeit;F. R. Waldenberger

354
Citations
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

Marianna Prokopi;Giordano Pula;Ursula Mayr;Cécile Devue

348
Citations
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.

G. Schett;Qingbo Xu;A. Amberger;R. Van Der Zee

340
Citations